Engineering adeno-associated virus vectors for gene therapy | Nature Reviews Genetics
A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy | Nature Biotechnology
Delivering gene therapy | Feature | Chemistry World
Gene editing for immune cell therapies | Nature Biotechnology
Gene therapy avenues and COVID-19 vaccines | Genes & Immunity
Patient and public perspectives on cell and gene therapies: a systematic review | Nature Communications
Gene therapy is facing its biggest challenge yet
The once and future gene therapy | Nature Communications
Delivery technologies to engineer natural killer cells for cancer immunotherapy | Cancer Gene Therapy
The therapeutic landscape for cells engineered with chimeric antigen receptors | Nature Biotechnology
CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma | Gene Therapy
Gene therapy - promises, problems and prospects | Nature
Genetic engineering of T cells for immunotherapy | Nature Reviews Genetics
The NIH Somatic Cell Genome Editing program | Nature
Realizing the promise of gene therapy through collaboration and partnering: Pfizer's view
The once and future gene therapy | Nature Communications
The transformative potential of HSC gene therapy as a genetic medicine | Gene Therapy
Overcoming cellular barriers for RNA therapeutics | Nature Biotechnology
Volume 15 Issue 3, September 2021
Non-viral vectors for gene-based therapy | Nature Reviews Genetics
Next-generation therapeutics: cell and gene therapy gathers pace
Delivering cellular and gene therapies to patients: solutions for realizing the potential of the next generation of medicine | Gene Therapy
Theranostic cells: emerging clinical applications of synthetic biology | Nature Reviews Genetics
